US OptionsDetailed Quotes

ABCL250117C6000

Watchlist

0.10
0.000.00%

15min DelayTrading Nov 11 10:53 ET

0.00High0.00Low

AbCellera Biologics Stock Discussion

insider trackerrr

May 20 04:56

Some things people may have missed from Stanley Druckenmiller’s latest 13F filings:

He added:
$iShares Russell 2000 ETF (IWM.US)$ —> $664M worth of calls, this to me is incredible…he really sees the broadening of this market to small caps
$Spdr Series Trust S&P Regional Bkg Etf (KRE.US)$ —> 307K shares, Stan likes regional banks…
$Reddit (RDDT.US)$ Reddit —> 175K shares, seems like he saw the need for real time data from platforms like Reddit
$Palo Alto Networks (PANW.US)$ Palo Alto Networks —> 74K sha...

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

Moomoo AI

Feb 29 07:15

Insiders at AbCellera Biologics Inc. are increasing their holdings, indicating optimism about the company's prospects. Their willingness to buy shares at a higher price suggests they see value in the company.

Insider Stock Buying Reaches US$1.61m On AbCellera Biologics

Moomoo AI

Dec 10, 2023 12:09

KeyBanc views current lower subsector stock prices as a valuable opportunity for long-term investors. The bank advises a detailed, company-specific approach to investment, highlighting Abcellera ($6), Absci ($3), and Schrodinger ($38) for their proven track records, AI focus, and recurring revenue growth, respectively.

KeyBanc Sees Opportunity in Tech-enabled Drug Discovery Stocks

Alvinnnnnnngenius

Nov 10, 2023 23:01

More insider loading huge and trading at bottoms now

$AbCellera Biologics (ABCL.US)$

Trytosaveabit

Nov 8, 2023 15:12

Inside buy

$AbCellera Biologics (ABCL.US)$ Director Montalbano John S. purchased 30,000 shares of Common Stocks on Nov 6, 8, 2023 at an average price of $4.58 for a total value of $137.4K.

Alvinnnnnnngenius

Nov 4, 2023 23:35

Quite number of insider loading this at 4.9 during sept and recently with good PR

$AbCellera Biologics (ABCL.US)$

Trytosaveabit

Nov 1, 2023 15:11

Update

$Prelude Therapeutics (PRLD.US)$ Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

Moomoo AI

Oct 28, 2023 09:11

The insider transactions at AbCellera Biologics suggest an alignment of interests with shareholders. The significant insider ownership and recent purchasing imply confidence in the company's prospects, even though it has been making losses.

AbCellera Biologics Insiders Placed Bullish Bets Worth US$2.34m

No comment yet